 coronari arteri thrombolysi comparison approv agent agent lysi thrombi coronari arteri alteplas anistreplas streptokinas undergon critic clinic experiment trial europ unit global comparison efficaci alteplas effect percent patenc anistreplas percent streptokinas percent streptokinas anistreplas allergen repeat administr feasibl short-term distinct advantag alteplas accur dose thrombolyt agent skill use aspirin heparin efficaci thrombolyt therapi risk recan rate percent thrombolyt agent first hour thrombosi administr develop thrombosi possibl agent hospit physician paramed